AUG 21, 2014 11:30 AM PDT

Understanding the Genetics of Common Disease: Using Big Data approaches to see the emergent whole

Speaker
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
    BIOGRAPHY

Abstract

The comprehensive, multidimensional molecular characterization of tumors and the individuals in which they have developed is transforming cancer definition, diagnosis, treatment, and prevention. These technologies identify the millions of variants present in normal individuals and thousands of alterations that occur during the course of tumor development. This systems-wide molecular analysis has identified a complex cacophony of inherited and acquired variation. The integration and interpretation of this complex multidimensional information into evidence exceeds raw human cognitive capacity. It presents challenges of contextualizing the data and converting it into actionable information.

Data Science has the capacity to provide the needed tools to tackle this challenge. Arizona State Universitys (ASU) Complex Adaptive Systems team is building a first generation Data Science research platform - the Next Generation Cyber Capability (NGCC). The ASU NGCC composed of hardware, software, and people transforms Big Data to information and creates the evidence necessary to enable personalized medicine. The NGCC permits data points to be evaluated in concert using Big Data analytic frameworks thereby identifying an emergent, coherent whole. Biologic network analysis represents one such promising integrative approach. These networks account for the individual heterogeneity in underlying etiology as well as the interaction of diverse events necessary to generate a complex phenotype such as cancer. Emerging collections of analytic approaches permit analysis using genome-wide data sets and established biologic networks as models.

These approaches are being applied to understand the origins and outcomes of cancer. Big Data approaches are identifying key biologic processes underpinning cancer susceptibility and oncogenesis. Novel analytic approaches are being applied to identify new strategies for intervention.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JUN 24, 2021 10:00 AM PDT
C.E. CREDITS
JUN 24, 2021 10:00 AM PDT
Date: June 24, 2021 Time: 10:00am PDT The Chan Zuckerberg Initiative (CZI) was founded to help solve some of society’s toughest challenges— from eradicating disease and improving...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
AUG 25, 2021 10:30 AM PDT
C.E. CREDITS
AUG 25, 2021 10:30 AM PDT
Emerging data from several expansive clinical trials indicates that common chronic vascular risk factors such as diabetes, hypertension, obesity, and age increase the risk of stroke and deme...
AUG 21, 2014 11:30 AM PDT

Understanding the Genetics of Common Disease: Using Big Data approaches to see the emergent whole


Specialty

Cancer

Personalized Medicine

Dna

Mass Cytometry

T-Cells

Cancer Research

Immunotherapeutics

Biomarkers

Oncology

Gene Sequencing

Publishing

Drug Discovery

Research And Development

Cell Culture

Immunity

Geography

Europe50%

Africa50%

Registration Source

Website Visitors100%

Job Title

Student50%

Medical Doctor/Specialist50%

Organization

Research Institute50%

Academic Institution50%


Show Resources
Loading Comments...
Show Resources